Suppr超能文献

β射线治疗眼球表面恶性黑色素瘤

beta-Ray treatment of malignant epibulbar melanoma.

作者信息

Lommatzsch P K

出版信息

Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Dec 15;209(2):111-24. doi: 10.1007/BF00407844.

Abstract

Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.

摘要

68例结膜黑色素瘤患者接受了β射线照射治疗。肿瘤表面给予的剂量在15000至20000拉德之间。75%的治疗是成功的。在67.4%的患者中,仅通过β射线照射就可以治愈黑色素瘤,随访期为3至10年。已证实的转移导致的致死率仅为6.2%。β治疗后的消退时间通常超过几个月。β射线可在肿瘤切除前或切除后使用。应注意确保施源器覆盖所有含有肿瘤细胞的组织。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验